首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Mental health clinician

缩写:

ISSN:2168-9709

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引450
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Loulwa Maktabi,Denver Shipman,Justin P Reinert Loulwa Maktabi
Introduction: Serotonin syndrome and neuroleptic malignant syndrome are caused by 2 distinct pathologies; however, the clinical presentation associated with both syndromes share many features. ...
Kyle Wesselman,Vincent Cavaliere,Rakesh Goyal et al. Kyle Wesselman et al.
Hyperammonemia is a well-known adverse effect of valproate that can progress to a potentially fatal condition known as valproate-induced hyperammonemic encephalopathy (VHE). VHE is more common when valproate is used in combination therapy w...
Bridgette M Gleisner,O Greg Deardorff,Yifei Liu et al. Bridgette M Gleisner et al.
Objective: Since 2017, Fulton State Hospital (FSH) has implemented a clozapine-induced constipation protocol. In March 2020, FSH initiated unit quarantines to minimize the spread of coronavirus disease (COVID-19). The obj...
Amber R Tran,Saumyaa A Patel,Lindsey J Loera et al. Amber R Tran et al.
Introduction: Mental health-related stigma is a barrier to treatment and recovery for serious mental illnesses (SMIs). Educational training programs demonstrate positive changes in health professional students' attitudes ...
Jonathan M Meyer,Craig Chepke,Rimal B Bera et al. Jonathan M Meyer et al.
Introduction: Two vesicular monoamine transporter 2 (VMAT2) inhibitors are approved in the United States (US) for the treatment of tardive dyskinesia (TD). There is a paucity of information on the impact of VMAT2 inhibito...
Alejandro Del Rio Verduzco,Ahva Salari,Parna Haghparast Alejandro Del Rio Verduzco
Introduction: Chronic insomnia affects 5% to 10% of the US population, increasing the demand for treatment options and the corresponding research to prove their validity.1 This review compares recommendations from 3 clini...
Daniel O Claassen,Rajeev Ayyagari,Viviana García-Horton et al. Daniel O Claassen et al.
Introduction: Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well und...
Kaitlyn Baldwin,Annabelle Wanson,Lee-Anne Gilecki et al. Kaitlyn Baldwin et al.
Background: Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limi...
Cambrey Nguyen,Karen E Moeller,Michael McGuire et al. Cambrey Nguyen et al.
Introduction: The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to consumers for complementary and medical purposes. However, there is a paucity of scientif...
Mohammad Adam Hamad,Andrew Williams,Jamie Kneebusch et al. Mohammad Adam Hamad et al.
Introduction: Urinary tract infections (UTIs) are one of the most common indications for antibiotic use; patients with psychiatric disorders have a greater risk for UTI compared with patients without these disorders. Howe...